Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Pancreatic cancer

Vincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,678

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126

Senescence-messaging secretome: SMS-ing cellular stress

Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786

When cells get stressed: an integrative view of cellular senescence

Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404

ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer

Jun, I., Park, H. S., Piao, H., Han, J. W., An, M. J., Yun, B. G., Zhang, X., Cha, Y. H., Shin, Y. K., Yook, J. I., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.355 · Cited by 46

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma

Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00184-0 · Cited by 47

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer

Group Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 48

Adenocarcinoma of the pancreas

Hruban, R. H., & Klimstra, D. S. (2014) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2014.08.004 · Cited by 47

Activated Wnt Signaling in Stroma Contributes to Development of Pancreatic Mucinous Cystic Neoplasms

Sano, M., Driscoll, D. R., DeJesus-Monge, W. E., Klimstra, D., & Lewis, B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.044 · Cited by 45

Mitochondrial uncoupling protein 2 and pancreatic cancer: A new potential target therapy

Donadelli, M., Dando, I., Pozza, E. D., & Palmieri, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i11.3232 · Cited by 46

MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 46

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49

High‐grade Pan IN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer

Yokode, M., Akita, M., Fujikura, K., Kim, M., Morinaga, Y., Yoshikawa, S., Terada, T., Matsukiyo, H., Tajiri, T., Abe‐Suzuki, S., et al. (2018) · Histopathology · doi:10.1111/his.13629 · Cited by 44

Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance

Okada, T., Mizukami, Y., Ono, Y., Sato, H., Hayashi, A., Kawabata, H., Koizumi, K., Masuda, S., Teshima, S., Takahashi, K., et al. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01724-5 · Cited by 44

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer

Singh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 43

A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease

Erickson, A. M., Hayes, A., Rajakumar, T., Verrill, C. L., Bryant, R. J., Hamdy, F. C., Wedge, D. C., Woodcock, D. J., Mills, I. G., & Lamb, A. D. G. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.02.008 · Cited by 45

Moving beyond Morphology: New Insights into the Characterization and Management of Cystic Pancreatic Lesions

Freeny, P. C., & Saunders, M. D. (2014) · Radiology · doi:10.1148/radiol.14131126 · Cited by 43

Nonviral Oncogenic Antigens and the Inflammatory Signals Driving Early Cancer Development as Targets for Cancer Immunoprevention

Chu, N. J., Armstrong, T. D., & Jaffee, E. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1186 · Cited by 43

Advances in oncolytic adenovirus therapy for pancreatic cancer

Nattress, C. B., & Halldén, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.006 · Cited by 43

Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma

Sagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 45

The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma

Lenk, L., Pein, M., Will, O., Gomez, B. A., Viol, F., Hauser, C., Egberts, J. D., Gundlach, J.-P., Helm, O., Tiwari, S., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1368603 · Cited by 42

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine

Yu, Y., Yang, G., Huang, H., Fu, Z., Cao, Z., Zheng, L., You, L., & Zhang, T. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01787-5 · Cited by 42

The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer

Fujii, A., Masuda, T., Iwata, M., Tobo, T., Wakiyama, H., Koike, K., Kosai, K., Nakano, T., Kuramitsu, S., Kitagawa, A., et al. (2021) · Cancer Science · doi:10.1111/cas.14858 · Cited by 41

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

Erice, O., Narayanan, S., Feliu, I., Entrialgo‐Cadierno, R., Malinova, A., Vicentini, C., Guruceaga, E., Delfino, P., Trajkovic‐Arsic, M., Moreno, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0794 · Cited by 41

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

Mannucci, A., & Goel, A. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70035 · Cited by 54

Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression

Fujikura, K., Akita, M., Abe‐Suzuki, S., Itoh, T., & Zen, Y. (2017) · Histopathology · doi:10.1111/his.13271 · Cited by 41

New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer

Imaoka, H., Sasaki, M., Hashimoto, Y., Watanabe, K., & Ikeda, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081173 · Cited by 42

Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage

Kirchweger, P., Kupferthaler, A., Burghofer, J., Webersinke, G., Jukic, E., Schwendinger, S., Weitzendorfer, M., Petzer, A., Függer, R., Rumpold, H. F., et al. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.11.138 · Cited by 40

Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E -tocotrienol

Husain, K. M., Centeno, B. A., Chen, D.-T., Fulp, W. J., Perez, M. C., Lee, G., Luetteke, N., Hingorani, S. R., Sebti, S. M., & Malafa, M. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt002 · Cited by 40

Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update

Esposito, I., Segler, A., Steiger, K., & Klöppel, G. (2015) · Pancreatology · doi:10.1016/j.pan.2015.08.007 · Cited by 39

Cells of origin of pancreatic neoplasms

Yamaguchi, J., Yokoyama, Y., Kokuryo, T., Ebata, T., & Nagino, M. (2017) · Surgery Today · doi:10.1007/s00595-017-1501-2 · Cited by 40

Persistent ferroptosis promotes cervical squamous intraepithelial lesion development and oncogenesis by regulating KRAS expression in patients with high risk-HPV infection

Wang, T., Gong, M., Cao, Y., Zhao, C., Lu, Y., Zhou, Y., Yao, S., Chen, J., Zhao, C. L., & Ju, R. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01013-5 · Cited by 40

Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular

Li, O., Li, L., Sheng, Y., Ke, K., Wu, J., Mou, Y., Liu, M., & Jin, W. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216391 · Cited by 38

Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey

Park, J. T., Johnson, N., Liu, S., Levesque, M., Wang, Y. J., Ho, H. H., Huso, D. L., Maitra, A., Parsons, M. J., Prescott, J. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.223 · Cited by 38

Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development

Peng, W., Furuuchi, N., Aslanukova, L., Huang, Y.-H., Brown, S. Z., Jiang, W.-W., Addya, S., Vishwakarma, V., Peters, E., Brody, J., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00427-17 · Cited by 35

Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib

Chien, W., Sudo, M., Ding, L., Sun, Q., Wuensche, P., Lee, K. L., Hattori, N., Garg, M., Xu, L., Zheng, Y., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25138 · Cited by 38

miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2

Dey, S., Kwon, J. J., Liu, S., Hodge, G. A., Taleb, S., Zimmers, T. A., Wan, J., & Kota, J. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0594 · Cited by 37

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification

Espiau-Romera, P., Courtois, S., Parejo-Alonso, B., & Sancho, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124128 · Cited by 43

Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma

Schofield, H. K., Zeller, J., Espinoza, C. E., Halbrook, C. J., Vecchio, A. D., Magnuson, B., Fabo, T., Daylan, A. E. C., Kovalenko, I., Lee, H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97422 · Cited by 38

The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma

Panzeri, V., Manni, I., Capone, A., Naro, C., Sacconi, A., Agostino, S. D., de Latouliere, L., Montori, A., Pilozzi, E., Piaggio, G., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12847 · Cited by 37

Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic TargetsPreprint

Drosten, M., Guerra, C. E., & Barbacid, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031542 · Cited by 43

ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis

YAN, H. H., Jung, K. H., Lee, J. E., Son, M. K., Fang, Z., Park, J. H., Kim, S., Kim, J., Lim, J. H., & Hong, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.036 · Cited by 34

Decoding the basis of histological variation in human cancer

Fujii, M., Sekine, S., & Sato, T. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00648-5 · Cited by 35

Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia

Pitarresi, J. R., Liu, X., Sharma, S. M., Cuitiño, M. C., Kladney, R. D., Mace, T. A., Donohue, S., Nayak, S. G., Qu, C., Lee, J., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.006 · Cited by 36

KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy

Trisolini, E., Armellini, E., Paganotti, A., Veggiani, C., Bozzola, C., Frattini, M., Pizio, C., Mancuso, G., Andorno, S., & Boldorini, R. L. (2017) · Pathology · doi:10.1016/j.pathol.2016.12.348 · Cited by 36

Histone methylation in pancreatic cancer and its clinical implications

Liu, X., Guo, C.-H., Xi, Z.-Y., Xu, X.-Q., Zhao, Q.-Y., Li, L., & Wang, Y. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i36.6004 · Cited by 36

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

Malinova, A., Veghini, L., Real, F. X., & Corbo, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795251 · Cited by 39

TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma

Pan, M., Jiang, C., Zhang, Z., Achacoso, N. S., Alexeeff, S., Solorzano, A. V., Tse, P., Chung, E. H., Sundaresan, T. K., Suga, J. M., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00570 · Cited by 38

GeLC-MRM Quantitation of Mutant KRAS Oncoprotein in Complex Biological Samples

Halvey, P. J., Ferrone, C. R., & Liebler, D. C. (2012) · Journal of Proteome Research · doi:10.1021/pr300161j · Cited by 36

Methylation of Tumor Suppressor Genes in Autoimmune Pancreatitis

Kinugawa, Y., Uehara, T., Sano, K., Matsuda, K., Maruyama, Y., Kobayashi, Y., Nakajima, T., Hamano, H., Kawa, S., Higuchi, K., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000804 · Cited by 35

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis

Ikezawa, K., Hikita, H., Shigekawa, M., Iwahashi, K., Eguchi, H., Sakamori, R., Tatsumi, T., & Takehara, T. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.02.001 · Cited by 35

Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis

Nissinen, S. I., Roine, A., Hokkinen, L., Karjalainen, M., VENÄLÄINEN, M. K., Helminen, H., Niemi, R. J., Lehtimäki, T. J., Rantanen, T. K., & Oksala, N. (2018) · Anticancer Research · doi:10.21873/anticanres.13081 · Cited by 35

Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer

Ding, L., & Billadeau, D. D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1743681 · Cited by 35

Recent advances in precision medicine for pancreatic ductal adenocarcinoma

Hayashi, H., Higashi, T., Miyata, T., Yamashita, Y., & Baba, H. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12436 · Cited by 36

Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy

Mortoglou, M., Tabin, Z. K., Arısan, E. D., Kocher, H. M., & Onganer, P. U. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101090 · Cited by 36

Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen

Sadakari, Y., Kanda, M., Maitani, K., Borges, M. W., Canto, M. I., & Goggins, M. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2014.14 · Cited by 35

Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae

Aravindan, S., Delma, C. R., Somasundaram, S. T., Herman, T. S., & Aravindan, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061977 · Cited by 34

Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas

Date, K., Ohtsuka, T., Fujimoto, T., Tamura, K., Kimura, H., Matsunaga, T., Mochidome, N., Miyazaki, T., Mori, Y., Oda, Y., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001755 · Cited by 34

Glycogen synthase kinase‐3β ablation limits pancreatitis‐induced acinar‐to‐ductal metaplasia

Ding, L., Liou, G., Schmitt, D. M., Störz, P., Zhang, J., & Billadeau, D. D. (2017) · The Journal of Pathology · doi:10.1002/path.4928 · Cited by 36

Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas

Sasaki, M., Nitta, T., Sato, Y., & Nakanuma, Y. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw071 · Cited by 34

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases

Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33

Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection

Hata, T., Mizuma, M., Motoi, F., Ohtsuka, H., Nakagawa, K., Morikawa, T., & Unno, M. (2022) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.1282 · Cited by 36

Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling

Fullerton, P. T., Creighton, C. J., & Matzuk, M. M. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1102 · Cited by 33

Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth

Vincent, A., Hong, S., Hu, C., Omura, N., Young, A., Kim, H., Yu, J., Knight, S., Ayars, M., Griffith, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1842 · Cited by 33

Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas

Zaccari, P., Cardinale, V., Severi, C., Pedica, F., Carpino, G., Gaudio, E., Doglioni, C., Petrone, M. C., Alvaro, D., Arcidiacono, P. G., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4343 · Cited by 35

Recent development of gene therapy for pancreatic cancer using non-viral nanovectors

Liu, Y., Wu, W., Wang, Y., Han, S., Yuan, Y., Huang, J., Shuai, X., & Peng, Z. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00748c · Cited by 35

Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples

Ideno, N., Mori, Y., Nakamura, M., & Ohtsuka, T. (2020) · Diagnostics · doi:10.3390/diagnostics10121056 · Cited by 32

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer

Tang, Y., Cao, G., Zhao, G., Wang, C., & Qin, Q. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00798-0 · Cited by 31

Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia

Opitz, F. V., Häberle, L., Daum, A., & Esposito, I. (2021) · Cancers · doi:10.3390/cancers13246188 · Cited by 35

Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin

Reichert, M., Blume, K., Kleger, A., Hartmann, D., & von Figura, G. (2015) · Stem Cells International · doi:10.1155/2016/9298535 · Cited by 35

Critical role of KRAS mutation in pancreatic ductal adenocarcinoma

Fan, Z., Fan, K., Yan, C., Huang, Q., Gong, Y., Cheng, H., Jin, K., Liu, C., Ni, Q., Yu, X., et al. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.10.19 · Cited by 30

Evolution of Cancer Progression in the Context of Darwinism

Lacina, L., Čoma, M., Dvořánková, B., Kodet, O., Melegová, N., Gál, P., & Smetana, K. (2018) · Anticancer Research · doi:10.21873/anticanres.13074 · Cited by 31

Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance

Rozengurt, E., & Eibl, G. (2021) · Cancers · doi:10.3390/cancers13205126 · Cited by 31

Origins of cancer: ain’t it just mature cells misbehaving?

Cho, C. J., Brown, J. W., & Mills, J. C. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00099-0 · Cited by 31

" Long non-coding RNA in pancreatic adenocarcinoma and pancreatic neuroendocrine tumors"

Moschovis, D. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0185 · Cited by 30

Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma

Terasawa, H., Kinugasa, H., Ako, S., Hirai, M., Matsushita, H., Uchida, D., Tomoda, T., Matsumoto, K., Horiguchi, S., Kato, H., et al. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1638685 · Cited by 31

Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma

Yamaguchi, T., Uemura, K., Murakami, Y., Kondo, N., Nakagawa, N., Okada, K., Seo, S., Hiyama, E., Takahashi, S., & Sueda, T. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09278-9 · Cited by 31

A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer

Du, Y., Shang, B.-Y., Sheng, W., Zhang, S., Li, Y., Miao, Q., & Zhen, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11170 · Cited by 29

Adenylyl cyclase 3/adenylyl cyclase‐associated protein 1 (CAP1) complex mediates the anti‐migratory effect of forskolin in pancreatic cancer cells

Quinn, S., Graves, S. H., Dains‐McGahee, C., Fechter, E. F., Hassan, H., Witkowski, P., & Sabbatini, M. E. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22598 · Cited by 29

Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm

Yamaguchi, J., Yokoyama, Y., Kokuryo, T., Ebata, T., Enomoto, A., & Nagino, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97755 · Cited by 29

Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception

Pedro, B. A., & Wood, L. D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191937 · Cited by 35

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux

Carozzo, A., Yaneff, A., Gomez, N. V., Siervi, N. D., Sahores, A., Diez, F., Attorresi, A. I., González, Á., Monczor, F., Fernández, N., et al. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115444 · Cited by 28

The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation

Guo, Y., Xiao, Y., Guo, H., Zhu, H., Chen, D., Wang, J., Deng, J., Lan, J., Liu, X., Zhang, Q., et al. (2021) · Aging · doi:10.18632/aging.203301 · Cited by 28

Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway

Fukunaga, Y., Fukuda, A., Omatsu, M., Namikawa, M., Sono, M., Masuda, T., Araki, O., Nagao, M., Yoshikawa, T., Ogawa, S., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.020 · Cited by 28

The Triple-Code Model for Pancreatic Cancer

Lomberk, G. A., & Urrutia, R. A. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.05.011 · Cited by 28

The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors

Zhao, R., Hu, Z., Zhang, X., Huang, S., Yu, G., Wu, Z. B., Yu, W., Lu, J., & Ruan, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01421-9 · Cited by 31

Pancreatic cancer from bench to bedside: molecular pathways and treatment options

Kosmidis, C. S., Sapalidis, K. G., Kotidis, E. V., Mixalopoulos, N., Zarogoulidis, P., Tsavlis, D., Baka, S., Man, Y.-G., & Kanellos, J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.11 · Cited by 26

Rab27a plays a dual role in metastatic propensity of pancreatic cancer

Kren, N. P., Michaud, D. E., Bagchi, S., Greene, K. G., & Pylayeva‐Gupta, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-64248-1 · Cited by 27

Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

Kane, L. E., Mellotte, G. S., Conlon, K. C., Ryan, B. M., & Maher, S. G. (2021) · Cancers · doi:10.3390/cancers13040769 · Cited by 28

Molecular alterations in pancreatic tumors

Visani, M., Acquaviva, G., Leo, A. D., Sanza, V., Merlo, L., Maloberti, T., Brandes, A. A., Franceschi, E., Battista, M. D., Masetti, M., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i21.2710 · Cited by 29

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

Bansod, S., Dodhiawala, P. B., & Lim, K. (2021) · Cancers · doi:10.3390/cancers13215481 · Cited by 28

Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer

Cortesi, A., Gandolfi, F., Arco, F., Chiaro, P. D., Valli, E., Polletti, S., Noberini, R., Gualdrini, F., Attanasio, S., Citron, F., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk5386 · Cited by 29

Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration

Kato, K., Kamada, H., Fujimori, T., Aritomo, Y., Ono, M., & Masaki, T. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/243524 · Cited by 27

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment

Long, S.-A., Amparo, A. M., Goodhart, G., Ahmad, S. A., & Waters, A. M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1402128 · Cited by 31

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

Tang, J., Zheng, Q., Wang, Q., Zhao, Y., Ananthanarayanan, P., Reina, C., Šabanović, B., Jiang, K., Yang, M.-H., Meny, C. C., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101692 · Cited by 26

mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma

Utomo, W. K., Narayanan, V., Biermann, K., van Eijck, C. H. J., Bruno, M. J., Peppelenbosch, M. P., & Braat, H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.014 · Cited by 27

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment

Lu, S., Ahmed, T., Du, P., & Wang, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061201 · Cited by 27

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

Liao, X., Han, C., Wang, X., Huang, K., Yu, T., Yang, C., Huang, R., Liu, Z., Han, Q., & Peng, T. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171293 · Cited by 27

Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer

Lin, J., Wu, Y., Liang, X., Ji, M., Ying, H., Wang, X., Sun, X., Shao, C., Zhan, L., & Zhang, Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22920 · Cited by 26

Current status of molecular diagnostic approaches using liquid biopsy

Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02024-4 · Cited by 26

Developments in Mirna Gene Signaling Pathways in Pancreatic Cancer

Vorvis, C., Κουτσιούμπα, Μ., & Iliopoulos, D. (2016) · Future Oncology · doi:10.2217/fon-2015-0050 · Cited by 28

Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia

Suh, H. N., Jun, S., Oh, A.-Y., Srivastava, M., Lee, S., Taniguchi, C. M., Zhang, S., Lee, W. S., Chen, J., Park, B.-J., et al. (2016) · Scientific Reports · doi:10.1038/srep38273 · Cited by 26

Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells

Bakke, J., Wright, W. C., Zamora, A. E., Oladimeji, P. O., Crawford, J. C., Brewer, C., Autry, R. J., Evans, W. E., Thomas, P. G., & Chen, T. (2019) · BMC Cancer · doi:10.1186/s12885-019-5455-1 · Cited by 26

Photosensitizers Binding to Nucleic Acids as Anticancer Agents

Xodo, L. E., Cogoi, S., & Rapozzi, V. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.180 · Cited by 26

Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor

Murphy, S. J., Hart, S. N., Lima, J. F., Kipp, B. R., Klebig, M. L., Winters, J. L., Szabo, C., Zhang, L., Eckloff, B. W., Petersen, G. M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.049 · Cited by 199

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269

Precursor Lesions of Pancreatic Cancer

Yonezawa, S., Higashi, M., Yamada, N., & Goto, M. (2008) · Gut and Liver · doi:10.5009/gnl.2008.2.3.137 · Cited by 91

KRAS2 Mutations in Human Pancreatic Acinar-Ductal Metaplastic Lesions Are Limited to Those with PanIN: Implications for the Human Pancreatic Cancer Cell of Origin

Shi, C., Hong, S., Lim, P., Kamiyama, H., Khan, M. A., Anders, R. A., Goggins, M., Hruban, R. H., & Eshleman, J. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0206 · Cited by 109

Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia

Ma, C., Gocke, C. D., Hruban, R. H., & Belchis, D. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.023 · Cited by 19